Literature DB >> 6176181

Processing of endogenous polypeptides by the lungs.

J W Ryan.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6176181     DOI: 10.1146/annurev.ph.44.030182.001325

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


× No keyword cloud information.
  7 in total

1.  A specific inhibitor of mammalian kallikrein, Phe-Phe-Arg-chloromethyl ketone, inhibits the production of vasoactive substances from trout plasma by kallikrein and blocks endogenous kallikrein-like activity in trout gills.

Authors:  D W Lipke; K R Olson
Journal:  Fish Physiol Biochem       Date:  1992-12       Impact factor: 2.794

2.  Dipeptidyl peptidase IV in mammalian lungs.

Authors:  E Krepela; J Viccar; L Zizková; E Kasafírek; Z Kolár; V Lichnovský
Journal:  Lung       Date:  1985       Impact factor: 2.584

3.  Angiotensin-converting enzyme labeled with [3H]captopril. Tissue localizations and changes in different models of hypertension in the rat.

Authors:  S K Wilson; D R Lynch; S H Snyder
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

4.  Early bronchopulmonary lesions in rat lung after normobaric 100% oxygen exposure and their evolution. A light and electron microscopic study.

Authors:  A Porte; J Mantz; C Hindelang; L Asmarats; S Viragh; M E Stoeckel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Preclinical pulmonary capillary endothelial dysfunction is present in brain dead subjects.

Authors:  Constantinos Glynos; Chariclea Athanasiou; Anastasia Kotanidou; Ioanna Korovesi; Katerina Kaziani; Olga Livaditi; Ioanna Dimopoulou; Nikolaos A Maniatis; Iraklis Tsangaris; Charis Roussos; Apostolos Armaganidis; Stylianos E Orfanos
Journal:  Pulm Circ       Date:  2013-04       Impact factor: 3.017

6.  Inhaled sodium cromoglycate to treat cough in advanced lung cancer patients.

Authors:  M Moroni; C Porta; G Gualtieri; G Nastasi; C Tinelli
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

Review 7.  Angiotensin II: a new therapeutic option for vasodilatory shock.

Authors:  Rachel L Bussard; Laurence W Busse
Journal:  Ther Clin Risk Manag       Date:  2018-07-26       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.